Govt Job: For Pharmacology, Life Sciences Job as Editorial Assistant at PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab, and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India, Pt. Jawahar Lal Nehru, who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Post : Editorial Assistant (One Post)

Applications are invited on a plain paper for the contractual post of Editorial Assistant in International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN) by Professor Bikash Medhi, Chief Editor, Department of Pharmacology, PGIMER, Chandigarh-160012. The post is purely on temporary basis.

Qualification :First Class Master’s Degree in Pharmacology / Life-Sciences from a recognized university.

Desirable : Experience in the Research field or scientific writing. Candidates with proficiency in computer application will be preferred

Age : As per GOI rules
Pay Scale : Rs. 35, 000/- per month (consolidated).

The above appointment will be purely on temporary basis. Interested candidates fulfilling the above conditions are required to submit their bio-data and necessary testimonials/ certificates by 6th May, 2022, through email at recruitmentmanpowereplpgimer@gmail.com

The candidates will be scrutinized by the selection committee and only short-listed candidates will be intimated through email/phone to attend the interview through online mode. No Separate interview letters will be sent.

Related Posts

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

New Delhi: The Parliamentary Panel on Health and Family Welfare has recommended various significant regulatory changes in the regulation of medical devices, including decentralisation of approval for all medical devices…

Diabetic drug metformin found to act on brain

NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory